Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
Financial Comparison: Modular Medical (NASDAQ:MODD) and EssilorLuxottica (OTCMKTS:ESLOY)
Modular Medical Announces 1-for-30 Reverse Stock Split
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
Modular Medical Announces Pricing of $4.68 Million Public Offering
Modular Medical Announces Proposed Public Offering
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Modular Medical Announces Ongoing Progress to Obtain CE Mark
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
Insiders Invested Millions in these Five Rebounding Stocks
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Modular Medical Announces $12 Million Private Placement
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
Modular Medical Announces Pricing of $8.2 Million Public Offering
Modular Medical Announces Proposed Public Offering
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Registration is Now Open for Tribe Public's Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
Modular Medical Announces Addition to the Russell Microcap(R) Index
New Video from Madison Liquidators Features the Best-Selling L-Shaped Desk